Navigation Links
Novalung Records 50% Growth
Date:3/23/2010

ANN ARBOR, Mich., March 23 /PRNewswire/ -- The innovative therapies for lung failure from medical device company Novalung GmbH continue to gain acceptance.  Additional financing will allow the Talheim (Germany) based company to accelerate the development of new products.

Novalung GmbH increased sales by 50% in 2009.  The increasing acceptance of the company's innovative therapies for lung failure both in Germany and abroad is driving continuing growth. Manufacturing operations moved into a new, larger clean-room facility at the end of 2009.

In order to maintain this growth and to fund further international expansion, the private equity group Zukunftsfonds Heilbronn GmbH & Co.KG ("Future Fund of Heilbronn", zfhn) and the LBank, state bank of Baden-Wurttemberg, completed an additional financing round for Novalung. The zfhn acted as lead investor for the second time.

Thanks to the additional funding, commercialization of new products can be pursued more aggressively. These measures put Novalung in an excellent position to establish itself internationally as the pioneering provider of solutions for lung failure, and to revolutionize the treatment of lung failure with new therapies.

Novalung products allow a paradigm shift from the mechanically ventilated patient in an artificial coma to the awake, mobile patient breathing spontaneously. The innovative technologies to replace mechanical ventilation and eliminate the associated ventilator-induced lung injury advance this approach and provide physicians, nurses and patients with new therapeutic options.

Novalung's vision for the future for the long-term treatment of patients with advanced lung disease is a small, wearable artificial lung that frees patients from respiratory stress, improves their overall condition and thus improves their quality of life.

Founded in 2003, Novalung GmbH operates on a highly international level in order to establish new solutions for lung failure. These advanced technologies from Germany and the U.S. were brought into the company and developed further.  Novalung's devices have been used to treat more than 5,000 patients.

The privately funded Novalung GmbH is a fast growing medical technology company based in the area of Heilbronn, Germany, with a subsidiary in Ann Arbor, Michigan.

Novalung has received limited FDA clearance to market its devices in the U.S., and the company plans to begin clinical trials here in 2010 to expand its indications in extracorporeal lung support.

SOURCE Novalung, Inc.

Back to top

RELATED LINKS
http://www.novalung.com

'/>"/>

SOURCE Novalung, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Praxis Electronic Medical Records Announces New Version 5 With Breakthrough in EHR Documentation
2. Aprima and MednetwoRx Partner to Provide Electronic Health Records and Remote Hosting Option to Physician Practices
3. Vicus Therapeutics Records Last Patient Visit of Phase 2, VT-122 Trial for the Treatment of Cachexia in Patients With Advanced Lung Cancer
4. Kensey Nash To Participate in the Sidoti Fourteenth Annual New York Emerging Growth Institutional Investor Forum
5. NOVAVAX to Present at 22nd Annual ROTH OC Growth Stock Conference
6. Vermillion to Present at the Roth 22nd Annual OC Growth Stock Conference March 15 - 17, Laguna Niguel, CA
7. Keryx Biopharmaceuticals to Present at the 22nd Annual ROTH OC Growth Stock Conference
8. Anadys Pharmaceuticals to Present at the ROTH OC Growth Stock Conference
9. International Growth Continues: Rhythmlink International, LLC Receives CE Marking & ISO 13485 Certification
10. DUSA Pharmaceuticals to Present at Roth Capital Partners 22nd Annual OC Growth Stock Conference
11. Acuo Technologies Announces Another Significant Sales and Implementation Growth Year
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2017)... 2017  As the specialty pharmacy industry and ... make the revolutionary shift from volume-based to value-based ... positive patient outcomes and shaping the future of ... away from clinical trials and toward data that ... drug therapy utilization in precise patient populations. Therigy ...
(Date:5/15/2017)... , May 15, 2017 Enterin Inc., a ... and developing novel compounds to treat Parkinson,s disease (PD), ... study is a Phase 1/2a randomized, controlled, multicenter study involving ... It will enroll 50 patients over a 9-to-12-month period. The ... in 10 patients with PD. Participating sites include ...
(Date:5/10/2017)... May 10, 2017 Global Health Intelligence ... Latin America , published its 2017 ranking of the ... based on extensive data analysis from GHI,s hospitals database ... database for the region. The GHI database covers 86% of ... more than 130 data points for each institution in key ...
Breaking Medicine Technology:
(Date:5/26/2017)... ... May 26, 2017 , ... Silver Birch of Hammond, ... is located on more than four acres of land at 5620 Sohl Avenue in ... The 103,000 square-foot building includes 125 studio and one-bedroom apartments. Each of the private ...
(Date:5/26/2017)... (PRWEB) , ... May 26, 2017 , ... “THE FLINTHILLS FAMILY-Our Journey to the Cross”: ... FAMILY-Our Journey to the Cross” is the creation of published authors, Bob and Margaret Massey. ... used to say, he is "panther quick and leather tough." His love for others ...
(Date:5/26/2017)... ... 2017 , ... Water damage to the flooring of several classrooms at The ... officials with a number of critical issues to address before students could return to ... with little or no disruption to class schedules. Second, the project had to comply ...
(Date:5/24/2017)... ... , ... Altec Products, Inc., a leader in enterprise document management ... conference in San Diego, CA. , At nVerge 2017, Altec will be highlighting ... enhance their Sage ERP solutions by providing improved visibility and control to the entire ...
(Date:5/24/2017)... ... May 24, 2017 , ... Patients who want to receive cosmetic dentistry procedures ... Dr. Joseph Bedich for a consultation, with or without a referral. Dr. Bedich enjoys ... functionality. , Dr. Bedich offers a variety of cosmetic dentistry services at ...
Breaking Medicine News(10 mins):